Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04757610 |
|---|---|
| Brief Title: | OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD) (ShORe) |
| First Submitted : | February 12, 2021 |
| First Submitted that Met QC Criteria : | February 15, 2021 |
| First Posted : | February 17, 2021 |
| Last Update Submitted that Met QC Criteria : | November 28, 2023 |
| Last Update Posted : | November 30, 2023 |